The Senate health committee will mark up FDA user fee legislation Wednesday (June 8), and the House will vote on its user fee bill, as lawmakers return from recess to a busy schedule that for now does not seem to include much on budget reconciliation and drug pricing, despite a debunked rumor that circulated over the weekend that a reconciliation deal was nigh. The Senate’s version of the user fee bill could be the target of new drug/pricing measures. Sen...